Innovative Research Award
| Ok Jun Lee | |
|---|---|
| Researcher | Ok Jun Lee |
| Affiliation | Chungbuk National University College of Medicine |
| Country | South Korea |
| Scopus ID | 7103020256 |
| Documents | 133 |
| Citations | 5,487 |
| h-index | 32 |
| Subject Area | Cancer Biotechnology |
| Event | Biotechnology Scientist Awards |
| ORCID | 0000-0002-5350-8751 |
Ok Jun Lee
Chungbuk National University College of Medicine, South Korea.
Ok Jun Lee is a researcher affiliated with Chungbuk National University College of Medicine, South Korea, whose scholarly work has contributed to the advancement of cancer biotechnology, molecular oncology, and translational biomedical research. The recognition presented through the Innovative Research Award highlights sustained academic productivity, scientific influence, and contribution to biotechnology-focused research initiatives.[1]
Abstract
This article presents a scholarly overview of Ok Jun Lee and the academic accomplishments associated with the Innovative Research Award. The profile examines research productivity, publication output, citation influence, and contributions to cancer biotechnology. The assessment reflects recognized indicators of scientific achievement, including peer-reviewed publications, citation performance, and sustained engagement in biomedical innovation.[1][2]
Keywords
Cancer Biotechnology; Molecular Oncology; Translational Medicine; Biomedical Research; Cancer Biomarkers; Biotechnology Innovation; Precision Medicine; Scientific Impact; Academic Excellence; Research Recognition.
Introduction
Biotechnology continues to play a central role in advancing healthcare through the development of diagnostic tools, therapeutic approaches, and molecular-level understanding of disease mechanisms. Researchers working within cancer biotechnology contribute to the identification of biomarkers, signaling pathways, and translational strategies aimed at improving patient outcomes. Within this context, Ok Jun Lee’s publication record demonstrates active participation in scientific investigations that align with contemporary challenges in oncology and biomedical sciences.[2][3]
Research Profile
Ok Jun Lee is affiliated with Chungbuk National University College of Medicine and has established a substantial research portfolio reflected through 133 indexed scholarly documents. The researcher’s citation performance exceeds 5,400 citations, while an h-index of 32 indicates consistent scholarly influence across multiple publications. Such indicators are commonly used in academic evaluation frameworks to assess research visibility and impact within scientific communities.[1][4]
The principal subject area associated with this profile is cancer biotechnology, encompassing investigations related to cancer biology, molecular diagnostics, therapeutic targets, and translational research methodologies. The interdisciplinary nature of biotechnology allows findings from laboratory studies to support clinical and healthcare applications.[3]
Research Contributions
The research contributions associated with Ok Jun Lee encompass scientific studies addressing molecular mechanisms involved in cancer progression, cellular regulation, and biomarker discovery. Publications within cancer biotechnology frequently contribute to the broader understanding of disease pathogenesis and therapeutic development.[5]
Additional scholarly activities include participation in collaborative research networks, peer-reviewed publication efforts, and dissemination of scientific findings through recognized academic channels. Such contributions support knowledge exchange and encourage innovation across biotechnology-related disciplines.[2]
Publications
The publication portfolio attributed to the researcher includes peer-reviewed journal articles and collaborative scientific studies indexed within major academic databases. Research outputs demonstrate sustained engagement with biotechnology and cancer-focused investigations, contributing to cumulative scientific knowledge and citation growth over time.[1][5]
- Peer-reviewed oncology and biotechnology publications.
- Collaborative multidisciplinary research studies.
- Scientific articles focusing on molecular and translational medicine.
- Research outputs contributing to citation-based scholarly impact.
Research Impact
Research impact may be assessed through citation metrics, publication quality, collaborative engagement, and knowledge translation. With more than 5,487 citations generated across thousands of citing documents, the scholarly work associated with Ok Jun Lee demonstrates visibility within the international research community. Citation-based indicators suggest that published findings have informed subsequent investigations and contributed to ongoing scientific discourse.[1][4]
Award Suitability
The Innovative Research Award recognizes researchers whose academic records demonstrate measurable contributions to scientific advancement. Based on documented publication output, citation performance, and engagement within cancer biotechnology, Ok Jun Lee presents characteristics commonly associated with candidates for academic recognition programs. Evaluation criteria such as scholarly productivity, research quality, and scientific influence align with the objectives of biotechnology-focused award initiatives.[1]
Conclusion
Ok Jun Lee’s academic profile reflects sustained involvement in cancer biotechnology research through a substantial body of publications, strong citation performance, and interdisciplinary scientific contributions. The Innovative Research Award profile serves as a structured overview of scholarly achievements and highlights the continuing importance of biotechnology research in advancing biomedical knowledge and healthcare innovation.[1][3]
External Links
References
-
- Elsevier. (n.d.). Scopus Author Details: Ok Jun Lee, Author ID 7103020256. Scopus Database.
https://www.scopus.com/authid/detail.uri?authorId=7103020256 - ORCID. (n.d.). ORCID Record for Ok Jun Lee.
https://orcid.org/0000-0002-5350-8751 - National Cancer Institute. (n.d.). Cancer Research and Biotechnology Resources.
https://www.cancer.gov/research - Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output.
- Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of Cancer: The Next Generation.
- Elsevier. (n.d.). Scopus Author Details: Ok Jun Lee, Author ID 7103020256. Scopus Database.